Developing technology to manage and advance female reproductive health care.


The Partnership Fund and the state’s Innovate NY program invested in Celmatix as part of its efforts to grow life sciences in New York. Funding supported this woman-led biotechnology company and the commercialization of academic research.


Biotech company that spun out of Weill Cornell Medicine that leverages predictive analytics and genomics to create products focused on the treatment of infertility and proactive fertility management.

Visit site